The present application relates to aminoalcohols and ketoamines of general formula I and to pharmaceutically acceptable salts and esters thereof, which interact with CNS receptors and can be used as drugs for the treatment of CNS diseases or, if opportunely labelled, with radioactive isotopes, as radioligands or tracers to study CNS receptors in vitro and in vivo.
本申请涉及通式I的
氨基醇和
酮胺,以及其药学上可接受的盐和
酯。这些化合物与中枢神经系统受体相互作用,可用作治疗中枢神经系统疾病的药物,或者如果适当标记为放射性同位素,则可用作体外和体内研究中枢神经系统受体的放射性
配体或示踪剂。